Alnylam Pharmaceuticals (ALNY) Q2 Earnings and Revenues Beat Estimates
ALNYAlnylam Pharmaceuticals(ALNY) ZACKS·2024-08-01 22:15

Alnylam Pharmaceuticals (ALNY) came out with quarterly earnings of 0.56pershare,beatingtheZacksConsensusEstimateofalossof0.56 per share, beating the Zacks Consensus Estimate of a loss of 0.74 per share. This compares to loss of 2.21pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof175.682.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 175.68%. A quarter ago, it was expected that this RNA interference drug developer would post a loss of 0.75 per share when it actually produced a loss of $0.16, delivering a surprise of 78.67%.Over t ...